0808 With the aim of achieving continuous growth and development, Maruho is establishing a solid management foundation to maintain accountable management. Maintaining a high equity-to-asset ratio, Maruho has received the high rating of “A-” by Rating and Investment Information, Inc. (R&I).We conduct our business according to our Corporate Mission, to contribute to better health for people all over the world. Since before I was president, I repeatedly asked myself what it specifically meant to “contribute to better health for people.” I reached the conclusion that it means to find unmet medical needs, which are overseen or neglected in society, and provide solutions that only Maruho can find, thereby making people smile. This is our mission inherited from our predecessors, and it is what I wish to achieve most as president. Let me present two examples of our addressing unmet medeical needs. Previously, atopic dermatitis was believed to be just an allergic disease. However, in the 1990s, barrier dysfunction of skin became recognized as an important factor and therefore the need for a skin-moisturizing agent arose from medical professionals and patients. In response to such needs, Maruho added a new indication to Hirudoid, which had been used as an anticoagulant and blood circulation promoter, and launched it as a skin-moisturizing agent. Maruho also responds to the needs of patients by providing correct information on diseases. For example, under the Third Medium-Term Plan from October 2017 to September 2020, we worked to promote the correct understanding of acne. We proactively communicated, in person and by digital media, that acne, which was often neglected as a symbol of youth, was a skin disease and that continued treatment is necessary to maintain clear skin without acne scars. Through this communication, we contributed to improving appropriate medical access for patients. Maruho is thus working to make many patients suffering from skin diseases smile by developing and proposing new treatments and by providing proper information.To achieve sustainable growth and further improve our corporate value in the future, it is necessary to formulate strategies and initiatives to be implemented from a medium- to long-term perspective, and ensure the initiatives are implemented. Based on this understanding, in October 2020 Maruho launched the Fourth Medium-Term Plan targeting three years until September 2023 as a concrete step toward realizing Long-Term Vision 2011. In the Fourth Medium-Term Plan, we have set six key strategies. By making steady progress with these strategies, we aim to make further contributions in dermatology.Our values, what only Maruho can provideFourth Medium-Term Plan
元のページ ../index.html#10